Regulation of Branched-chain Amino Acid Metabolism in Pre-Diabetes
BCAAM-PD
1 other identifier
interventional
132
1 country
1
Brief Summary
Elevated circulating levels of certain amino acids (the building blocks of protein) are strongly associated with insulin resistance. This study will investigate the metabolism of these amino acids in individuals with normal glucose metabolism compared to overweight or obese pre-diabetic individuals. The purpose of this study is to determine how elevated levels of the branched-chain amino acids may contribute to the development of insulin resistance and ultimately diabetes. An additional purpose is to determine whether exercise or gastric bypass (GBP) surgery intervention can correct aberrations in branched-chain amino acid metabolism as insulin sensitivity improves. This information will be used to further our understanding of the development of insulin resistance and type 2 diabetes in at-risk populations and potentially improve clinical treatment of such conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 6, 2013
CompletedFirst Posted
Study publicly available on registry
February 8, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedOctober 19, 2015
October 1, 2015
1.5 years
February 6, 2013
October 15, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Branched-chain Amino Acid Metabolism in Pre-Diabetes at Baseline and post-intervention
1. Lean Healthy Controls - Baseline only 2. Pre-Diabetic Group - Baseline and 6-months post the Aerobic and Resistance combined exercise training intervention 3. Gastric Bypass Group - Baseline and 3-months post Gastric Bypass surgery
Baseline and pre- and post-intervention: 1) Lean Group-Baseline measures only; 2)Pre-Diabetic group - Baseline and 6-months post exercise intervention; 3) GBP group - Baseline and 3-months post Gastric Bypass Surgery
Secondary Outcomes (1)
Changes in Insulin Sensitivity at Baseline and post-intervention
Baseline and pre- and post-intervention: 1) Lean Group-Baseline measures only; 2)Pre-Diabetic group - Baseline and 6-months post exercise intervention; 3) GBP group - Baseline and 3-months post Gastric Bypass Surgery
Study Arms (3)
Lean Group
NO INTERVENTIONHealthy Controls - no intervention
Pre-Diabetes Group
OTHERPre-Diabetes Group will undergo a 6-mo Aerobic and Resistance combined exercise training intervention
Gastric Bypass Group
OTHERNon-diabetic patients intending to undergo Gastric Bypass surgery
Interventions
Eligibility Criteria
You may qualify if:
- Age:
- Lean and Overweight Pre-diabetic (PD) groups: 40-65 years
- Obese Gastric Bypass (GBP) patients: 30-65 years
- Body Mass Index (BMI) within desired range for group:
- Lean group: 18.0 - 24.9
- Overweight PD group: 25.0 - 35.4
- GBP group: 35.0 - 50.0
- Fasting Plasma Glucose level within desired range for group:
- Lean: \< 99 mg/dL
- PD: \> 105 - \< 126 mg/dL
- GBP: \> 99
- Oral Glucose Tolerance Test, 2-hour Plasma Glucose results within desired range:
- Lean: \< 139 mg/dL
- PD: 140-199 mg/dL
- Low density (LDL) cholesterol: \< 190 mg/dL
- +6 more criteria
You may not qualify if:
- Smoker: Tobacco use within the last 12 months
- Dieting or intending to diet (excluding intention for gastric bypass procedure in GBP group)- Not weight stable for \> six months or weight loss exceeding five pounds in last six months
- Use of potential confounding medications, e.g. Niacin containing drugs
- History of diabetes, heart disease or taking medication for those conditions
- History of hypertension (high blood pressure) not controlled with medication
- Pregnant or intending to become pregnant
- Unwillingness to participate in study visits, submit to skeletal muscle biopsies and all other study testing or continuously participate in the exercise training intervention program for six months if in overweight PD group
- Orthopedic limitations, musculoskeletal disease and/or injury
- Allergic to xylocaine
- Inability to give blood continuously through an intravenous catheter
- Unwillingness to exercise at least three times per week at the Duke Center for Living during staff supervised times (PD only)
- Exercise compliance less than 85% in any 6 week period (missing \> 3 exercise sessions in a 6 week period)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- Pfizercollaborator
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27710, United States
Related Publications (1)
Glynn EL, Piner LW, Huffman KM, Slentz CA, Elliot-Penry L, AbouAssi H, White PJ, Bain JR, Muehlbauer MJ, Ilkayeva OR, Stevens RD, Porter Starr KN, Bales CW, Volpi E, Brosnan MJ, Trimmer JK, Rolph TP, Newgard CB, Kraus WE. Impact of combined resistance and aerobic exercise training on branched-chain amino acid turnover, glycine metabolism and insulin sensitivity in overweight humans. Diabetologia. 2015 Oct;58(10):2324-35. doi: 10.1007/s00125-015-3705-6. Epub 2015 Aug 9.
PMID: 26254576DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William E. Kraus, MD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2013
First Posted
February 8, 2013
Study Start
June 1, 2012
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
October 19, 2015
Record last verified: 2015-10